In vitro and in vivo profiling of CHF5022 and CHF5074

This publication has 34 references indexed in Scilit:

• A Novel Phospholipid Derivative of Indomethacin, DP-155 [Mixture of 1-Steroyl and 1-Palmitoyl-2-{6-[1-(p-chlorobenzoyl)-5-methoxy-2-methyl-3-indolyl acetamido]hexanoyl}-sn-glycero-3-phosophatidyl Choline], Shows Superior Safety and Similar Efficacy in Reducing Brain Amyloid β in an Alzheimer’s Disease Model
  The Journal of Pharmacology and Experimental Therapeutics, 2006
• Synthesis and Biological Activity of Flurbiprofen Analogues as Selective Inhibitors of β-Amyloid_1-42Secretion
  Journal of Medicinal Chemistry, 2005
• Transgenic AD model mice, effects of potential anti-AD treatments on inflammation and pathology
  Brain Research Reviews, 2005
• Modulation of Nuclear Factor-κB Activity by Indomethacin Influences Aβ Levels but Not Aβ Precursor Protein Metabolism in a Model of Alzheimer's Disease
  The American Journal of Pathology, 2004
• The potential role of non-steroidal anti-inflammatory drugs in treating Alzheimer’s disease
  Expert Opinion on Investigational Drugs, 2004
• Selected Non-steroidal Anti-inflammatory Drugs and Their Derivatives Target γ-Secretase at a Novel Site
  Journal of Biological Chemistry, 2004
• Aβ42-lowering Nonsteroidal Anti-inflammatory Drugs Preserve Intramembrane Cleavage of the Amyloid Precursor Protein (APP) and ErbB-4 Receptor and Signaling through the APP Intracellular Domain
  Journal of Biological Chemistry, 2003
• Inflammation and cerebral amyloidosis are disconnected in an animal model of Alzheimer's disease
  Journal of Neuroimmunology, 2003
• A γ‐secretase inhibitor blocks Notch signaling in vivo and causes a severe neurogenic phenotype in zebrafish
  EMBO Reports, 2002
• Inhibition of Noxious Stimulus‐Induced Spinal Prostaglandin E₂ Release by Flurbiprofen Enantiomers
  Journal of Neurochemistry, 2000